# Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

> **NCT02542969** · PHASE1 · COMPLETED · sponsor: **Madrigal Pharmaceuticals, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Rosuvastatin
- **DRUG:** MGL-3196

## Key facts

- **NCT ID:** NCT02542969
- **Lead sponsor:** Madrigal Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542969, "Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02542969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*